0001757610-21-000002.txt : 20211103 0001757610-21-000002.hdr.sgml : 20211103 20211103122908 ACCESSION NUMBER: 0001757610-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211103 DATE AS OF CHANGE: 20211103 EFFECTIVENESS DATE: 20211103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zyus Life Sciences Inc. CENTRAL INDEX KEY: 0001757610 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-419644 FILM NUMBER: 211374460 BUSINESS ADDRESS: STREET 1: 407 DOWNEY RD STREET 2: SUITE 204 CITY: SASKATOON STATE: A9 ZIP: SLN4L8 BUSINESS PHONE: 306-651-7711 MAIL ADDRESS: STREET 1: 407 DOWNEY RD STREET 2: SUITE 204 CITY: SASKATOON STATE: A9 ZIP: SLN4L8 FORMER COMPANY: FORMER CONFORMED NAME: CB3 Life Sciences Ltd. DATE OF NAME CHANGE: 20181030 D 1 primary_doc.xml X0708 D LIVE 0001757610 Zyus Life Sciences Inc. 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 306-651-7711 SASKATCHEWAN, CANADA CB3 Life Sciences Ltd. Corporation true 2018 BRENT ZETTL 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Executive Officer Director PRESIDENT and CEO Rob Harding 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Executive Officer Chief Financial Officer Keith Carpenter 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Executive Officer Chief Strategy and Investment Officer John Knowles 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Director Richard Hoyt 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Director Donald Ching 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Director Garnette Weber 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Director Other Health Care Decline to Disclose 06b false 2021-10-20 false true true false 100000 5000000 2068000 2932000 The Total Amount Sold is CAD 2,575,000 and was converted for this Form D filing to USD using the conversion rate on 11/3/21 of 1 USD = 1.24 CAD. false 2 0 0 0 false Zyus Life Sciences Inc. Brent Zettl Brent Zettl President and CEO 2021-11-03